Lyell Immunopharma to Present at Three March Investor Conferences
Event summary
- Lyell Immunopharma to present at TD Cowen Health Care Conference on March 2, 2026.
- Company scheduled for Leerink Global Healthcare Conference on March 9, 2026.
- Citizens Life Science Conference participation on March 10, 2026.
- All presentations available via live webcast on Lyell's investor relations page.
The big picture
Lyell Immunopharma's participation in three major investor conferences in March 2026 underscores its push to highlight advancements in CAR T-cell therapies. The company's focus on enhancing tumor cytotoxicity and manufacturing scale comes amid growing competition in the cell therapy space. Investors will be watching for updates on clinical trial progress and commercialization timelines.
What we're watching
- Pipeline Progress
- How Lyell's next-generation CAR T-cell therapies will perform in clinical trials.
- Manufacturing Scale
- Whether Lyell's LyFE Manufacturing Center can sustain commercial launch capacity.
- Investor Sentiment
- The market reaction to Lyell's strategic updates during March conferences.
Related topics